Genell L. Knatterud

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial

H. Vernon Anderson, Christopher P. Cannon, Peter H. Stone et al. · Journal of the American College of Cardiology · 1995 · 344 citations

Medicine, Cardiology, Clinical Cardiology +14

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

Simoons Ml, Peter de Jaegere, Ron van Domburg et al. · The Lancet · 1993 · 298 citations · Full text

Medicine, Neurosurgery, Cerebrovascular Neurosurgery +14

Thrombolysis in myocardial Infarction (TIMI) trial–phase I

Rao Ak, C. M. Pratt, Andrew Berke et al. · Dimensions of Critical Care Nursing · 1990 · 120 citations

Medicine, Cardiology, Pharmacology +12

Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial

Hiltrud S. Mueller, Sandra Forman, Mark Menegus et al. · Journal of the American College of Cardiology · 1995 · 67 citations

Medicine, Cardiology, Clinical Sciences +12